Home / Diseases Index / Reactive Arthritis
๐Ÿฉบ Clinical Pathology & Repertory Reference

Reactive Arthritis

Comprehensive Diagnostic & Therapeutic Reference Profile

Also known as: Reiterโ€™s Syndrome (obsolete), SARA (Sexually Acquired Reactive Arthritis), Post-infectious Arthritis.

๐Ÿ“–
Section 1

Disease Overview

Reactive arthritis (ReA) is an inflammatory spondyloarthropathy characterized by sterile joint inflammation that develops following a primary infection at a distant site, typically the gastrointestinal (GI) or urogenital (UG) tract. It is characterized by the classic clinical triad of arthritis, urethritis, and conjunctivitis, though many patients do not present with all three. It primarily affects the large lower extremity joints and is strongly associated with the HLA-B27 genetic marker.

๐Ÿฅ
Section 2

Medical Classification

Disease Category
Rheumatological Disorders
ICD Classification
ICD-10: M02 (Reactive arthropathies) ICD-11: FA13.0 (Reactive arthritis)
๐Ÿงฌ
Section 3

Etiology & Causes

Reactive arthritis is caused by an aberrant immune response to a preceding bacterial infection. The most common causative pathogens include:
Urogenital: Chlamydia trachomatis* (the most frequent trigger).
Gastrointestinal: Salmonella, Shigella, Campylobacter, Yersinia, and Clostridioides difficile*.


  • Genetic Factors: Approximately 30% to 50% of patients possess the HLA-B27 allele, which increases susceptibility and severity.

โš™๏ธ
Section 4

Pathophysiology

The pathogenesis involves "molecular mimicry" or an immune-mediated reaction. Bacterial antigens (lipopolysaccharides or DNA/RNA) persist in the synovium despite the absence of live, culturable organisms in the joint. These antigens trigger a T-cell-mediated response. In HLA-B27 positive individuals, the MHC class I molecule may misfold or present bacterial peptides to CD8+ T cells in a way that promotes cross-reactivity with self-antigens in the joints and entheses, leading to chronic inflammation.

๐Ÿ“Š
Section 5

Epidemiology

  • Prevalence: Approximately 0.1% of the general population.
  • Age: Primarily affects young adults aged 20โ€“40 years.
  • Gender: Urogenital-triggered ReA is more common in males (up to 9:1 ratio), while gastrointestinal-triggered ReA affects males and females equally.
โš ๏ธ
Section 6

Risk Factors

  • Recent history of bacterial diarrhea or sexually transmitted infection.
  • Presence of the HLA-B27 genotype.
  • Immunocompromised status (e.g., HIV/AIDS).
  • Male gender (specifically for Chlamydia-induced ReA).
๐Ÿค’
Section 8

Symptoms

A. Early Symptoms


  • Urethral discharge or dysuria.

  • Mild diarrhea.

  • Low-grade fever and malaise. B. Common Symptoms

  • Asymmetric Oligoarthritis: Primarily involving the knees, ankles, and feet.

  • Enthesitis: Inflammation at tendon insertion sites, specifically the Achilles tendon (heel pain).

  • Dactylitis: "Sausage digits" (swelling of an entire finger or toe).

  • Conjunctivitis: Redness and irritation of the eyes. C. Advanced Symptoms

  • Keratoderma Blennorrhagica: Hyperkeratotic skin lesions on palms or soles.

  • Circinate Balanitis: Painless ulcers on the glans penis.

  • Sacroiliitis: Lower back pain radiating to the buttocks. D. Emergency Symptoms

  • Acute vision loss (secondary to severe uveitis).

  • High fever with severe joint swelling (requires exclusion of septic arthritis).

๐Ÿฉบ
Section 9

Physical Examination

  • Vitals: Possible low-grade fever.
  • Joints: Warmth, swelling, and decreased range of motion in affected joints (usually asymmetric).
  • Skin/Mucosa: Check for circinate balanitis, oral ulcers, and keratoderma blennorrhagica.
  • Eyes: Scleral injection or signs of anterior uveitis (photophobia, redness).
  • Entheses: Tenderness over the tibial tuberosity or calcaneus.
๐Ÿ”
Section 10

Diagnostic Evaluation

A. Clinical Assessment: Diagnosis is primarily clinical, based on the pattern of arthritis and history of preceding infection.
B. Laboratory Testing: ESR/CRP elevation; screening for Chlamydia/enteric pathogens.
C. Imaging Studies: X-rays of the feet, ankles, and sacroiliac joints.
D. Functional Tests: Range of motion assessment.
E. Biopsy Findings: Synovial biopsy shows nonspecific inflammatory changes (rarely performed).
F. Genetic Testing: HLA-B27 testing to assess risk for chronicity.
G. Differential Diagnosis: Septic arthritis, Gout, Rheumatoid Arthritis, Psoriatic Arthritis.

๐Ÿงช
Section 11

Laboratory Tests

C-Reactive Protein (CRP) / ESR
Type: Blood Test
Purpose: To assess systemic inflammation.
Expected Findings: Elevated levels.
Interpretation: Indicates active inflammatory process but is non-specific. Chlamydia NAAT
Type: Urine or Swab Test
Purpose: To identify the triggering urogenital infection.
Expected Findings: Positive for C. trachomatis.
Interpretation: Confirms the presence of a triggering organism. Arthrocentesis (Synovial Fluid Analysis)
Type: Joint Fluid Aspiration
Purpose: To rule out septic arthritis and crystals.
Expected Findings: High WBC count (neutrophils), negative culture, no crystals.
Interpretation: Confirms sterile inflammatory arthritis.

๐Ÿ“ท
Section 12

Imaging Studies

  • X-ray: Early stages often appear normal. Chronic cases may show periosteal reaction, joint space narrowing, or "fluffy" calcaneal spurs.
  • Ultrasound: Highly sensitive for detecting subclinical enthesitis and dactylitis.
  • MRI: Used for detecting early sacroiliitis (bone marrow edema) that is not visible on X-ray.
๐Ÿ”€
Section 13

Differential Diagnosis

  • Septic Arthritis: Usually monoarticular; positive joint fluid culture; requires immediate antibiotic treatment.
  • Disseminated Gonococcal Infection: Often presents with tenosynovitis and skin pustules.
  • Gout: Presence of monosodium urate crystals in synovial fluid.
  • Psoriatic Arthritis: Similar dactylitis but usually involves the distal interphalangeal joints and classic psoriasis plaques.
๐Ÿ’ข
Section 14

Complications

  • Chronic arthritis/Joint deformity.
  • Ankylosing spondylitis.
  • Aortic regurgitation or conduction defects (rare).
  • Cystoid macular edema or glaucoma (secondary to uveitis).
๐Ÿ’Š
Section 15

Treatment Options

A. Lifestyle Modifications: Weight management to reduce joint stress; physical therapy.
B. Preventive Measures: Safe sex practices and proper food hygiene.
C. Medical Treatment


  • NSAIDs (First-line): Naproxen, Indomethacin (reduces pain and inflammation).

  • Corticosteroids: Intra-articular injections for localized flares or oral prednisone for systemic involvement.

  • DMARDs: Sulfasalazine or Methotrexate (for chronic or refractory cases).

  • Biologics: TNF-alpha inhibitors (e.g., Etanercept, Adalimumab) for severe, chronic ReA.


Antibiotics: Indicated only to treat the active* underlying infection (e.g., Doxycycline for Chlamydia). D. Surgical Treatment: Rare; only in cases of severe joint destruction (arthroplasty).
E. Interventional Procedures: Arthrocentesis for joint decompression.
F. Rehabilitation: Physical therapy to prevent muscle atrophy and maintain joint mobility.
G. Emergency Management: Management of acute uveitis with topical steroids to prevent blindness.

๐Ÿ“‰
Section 16

Prognosis

Most patients (approx. 60โ€“80%) experience a self-limiting course with resolution within 3โ€“12 months. However, 15โ€“20% of cases become chronic, requiring long-term DMARD therapy. HLA-B27 positivity is associated with a higher risk of recurrence and progression to spondylitis.

๐Ÿ›ก๏ธ
Section 17

Prevention

Primary prevention involves the use of condoms to prevent STIs and adherence to food safety guidelines to avoid enteric pathogens. Secondary prevention involves prompt treatment of the initial infection to potentially reduce the severity of the subsequent immune response.

๐ŸŒฟ
Section 19

Homeopathic Perspective

The following homeopathic remedies have been historically indicated for symptoms associated with Reactive Arthritis. Selection should be based on individualized symptom totality and constitutional assessment.

๐Ÿ“ Clinical Notes:
Comprehensive guide to Reactive Arthritis (formerly Reiter's Syndrome), covering etiology, post-infectious triggers, treatment options, and the HLA-B27 connection.
โ“
Section 20

FAQs

Q: What is Reactive Arthritis? โ–ผ
Reactive arthritis (ReA) is an inflammatory spondyloarthropathy characterized by sterile joint inflammation that develops following a primary infection at a distant site, typically the gastrointestinal (GI) or urogenital (UG) tract. It is characterized by the classic clinical triad of arthritis, ure...
Q: What are the main symptoms of Reactive Arthritis? โ–ผ
**A. Early Symptoms** * Urethral discharge or dysuria. * Mild diarrhea. * Low-grade fever and malaise. **B. Common Symptoms** * **Asymmetric Oligoarthritis:** Primarily involving the knees, ankles, and feet. * **Enthesitis:** Inflammation at tendon insertion sites, specifically the Achilles tendon (...
Q: What causes Reactive Arthritis? โ–ผ
Reactive arthritis is caused by an aberrant immune response to a preceding bacterial infection. The most common causative pathogens include: * **Urogenital:** *Chlamydia trachomatis* (the most frequent trigger). * **Gastrointestinal:** *Salmonella*, *Shigella*, *Campylobacter*, *Yersinia*, and *Clos...
Q: Which homeopathic remedies are recommended for Reactive Arthritis? โ–ผ
Based on clinical repertory references, recommended remedies include: Magnesia Phosphorica, Sulphur. Selection should be individualized based on the patient's complete symptom picture.
Q: When should I see a doctor for Reactive Arthritis? โ–ผ
Consult a healthcare professional if you experience persistent or worsening symptoms, or if the condition significantly impacts your daily activities.
๐Ÿ“š
Section 21

References

  • Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) โ€” Primary clinical reference
  • Robin Murphy โ€” Lotus Materia Medica (3rd Edition)
  • William Boericke โ€” Pocket Manual of Homล“opathic Materia Medica & Repertory
  • ICD-10/ICD-11 Classification โ€” World Health Organization
  • Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

๐Ÿ“Š
Section 22

Clinical Calculator

๐Ÿ“Š Inflammation & Joint Health Analyzer

Interprets CRP, ESR, Uric Acid, and Rheumatoid Factor to detect systemic inflammation, Gout risk, and Rheumatoid Arthritis likelihood.

๐Ÿงช Inflammation & Joint Health Analyzer

Interprets CRP, ESR, Uric Acid, and Rheumatoid Factor to detect systemic inflammation, Gout risk, and Rheumatoid Arthritis likelihood.

Enter your clinical parameters to see dynamic diagnostic readings.

๐Ÿ“Š Inflammation & Joint Health Analyzer

Interprets CRP, ESR, Uric Acid, and Rheumatoid Factor to detect systemic inflammation, Gout risk, and Rheumatoid Arthritis likelihood.

๐Ÿš€ Open Calculator Page

Clinical Specifications

Reference ID CPD-90258
Disease Group Rheumatological Disorders
Content Sections 20 Active Sections

Clinical Consultation

Speak with our specialists for a customized treatment protocol for this condition.

๐Ÿ“… Request Consultation

Medical Disclaimer

This clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.

Advertisement
๐Ÿ“– Click any word to see its definition instantly! ร—
https://amzn.to/46KgzJn